Evaluation of surrogate markers and cognitive reserve related to Alzheimer's disease - Multimodal Neuroimaging for AD with Biomarker (MULNIAD-B)

ational Center for Geriatrics and Gerontology0 sites200 target enrollmentJanuary 8, 2015

ConditionsHealthy volunteer Alzheimer&#39 s disease (AD) Mild cognitive impairment (MCI)

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy volunteer Alzheimer&#39
Sponsor: ational Center for Geriatrics and Gerontology
Enrollment: 200
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

akamura A, et al. Early functional network alterations in asymptomatic elders at risk for Alzheimer's disease. Scientific reports. 2017;7(1):6517. Nakamura A, et al. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease. Brain. 2018;141(5):1470-1485.

Registry

who.int

Start Date

January 8, 2015

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

ational Center for Geriatrics and Gerontology

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Any significant neurological or psychiatric disease other than dementia Any significant disease such as cancer and heart disease Psychiatric symptoms